FluoretiQ Ltd., the Bristol-based medical technology company fighting the spread of antimicrobial resistance, has announced the appointment of Dana Marshall, a veteran of the in-vitro diagnostics sector, to its Board of Directors.

Marshall is a serial entrepreneur who has founded and led several US businesses over the last 30 years and driven the development and launch of numerous...

A Bristol-based medical technology company fighting the spread of antimicrobial resistance has announced the appointment of its first chief medical officer.

Fluoretiq , which was founded in 2017 and has developed a diagnostic tool called NANOPLEX, named Kasra Saeb-Parsy to the senior role as the company moves a step closer to clinical studies and regulatory approval in the UK and USA...